Danny Talati

Doer
DISC Type : ds

Vice President Corporate Development at PsychoGenics

New York, New York, United States

Overview

Danny is a biopharma executive with over 20 years of experience in business development and corporate strategy, specializing in neuroscience and neurology. Holding both a PharmD from Northeastern University and an MBA from London Business School, he currently leads corporate development at PsychoGenics, focusing on partnerships and capital raising.

His recent professional focus has been on advancing innovative treatments for mental health and neuropsychiatric disorders across several companies. He actively promotes novel drug discovery technologies and seeks out investment and in-licensing opportunities to grow the CNS pipeline.

During his first week at PsychoGenics, the company announced an exclusive global license for an innovative compound to treat neuropsychiatric disorders.

Personality Overview

Long-term Focused

Deliberate Doer

Risk-Accepting

They might take some time to make their mind up but once they do, they don't change it easily.  Reading between the lines and seeing beyond your words comes naturally to them. They are very professional in their approach and can weigh multiple perspectives together.

Topics They Care About

Neuropsychiatry Treatments
His career at PsychoGenics, ATAI Life Sciences, and Fortress Biotech has centered on developing and acquiring novel treatments for mental health and neurodegenerative disorders.
AI Drug Discovery
He actively promotes PsychoGenics' AI-enabled drug discovery platforms like SmartCube, highlighting their value in identifying new neuropsychiatry treatments.
Biopharma Deal-Making
His roles consistently involve identifying in-licensing deals, securing equity investments, and forming strategic partnerships to build company pipelines.

Media Appearances

Danny has no verified media appearances

Work History

8-2023 - 4-2025
Vice President Corporate Development at PsychoGenics
5-2022 - 6-2023
Senior Vice President, Corporate Strategy at Cognesy Therapeutics
4-2019 - 5-2022
Head, Business Development at ATAI Life Sciences AG
2-2016 - 6-2018
Director, New Business Development at Fortress Biotech
1-2014 - 1-2016
Director, Professional Services (BD consulting) at Torreya Insights

Education

2006 - 2008
MBA from London Business School
1995 - 2001
PharmD from Northeastern University

More Information

Social Presence :

Prographics :

Exp : 19 Location : New York, New York, United States Job Level : N/A Designation : Vice President Corporate Development at PsychoGenics
URL has been copied!

Insights For Selling To Danny

During A Call Or A Meeting

DO's

  • Stick to your standard pitch and qualifying script, don't try to wing it
  • Come across as a trustworthy professional and be respectful, they usually know their game
  • Use phrases like 'your team deserves', 'best in class' etc.

DONT's

  • Don't get into pricing discussions early on, steer conversation towards proven results
  • Don't take their patience for granted, avoid long-winding sermons
  • Avoid putting conscious effort into relationship-building

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Danny is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Danny

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Danny move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Danny take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Danny

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.